UK2 Stock Overview
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People’s Republic of China.
Shandong Weigao Group Medical Polymer Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$0.91|
|52 Week High||HK$2.16|
|52 Week Low||HK$0.88|
|1 Month Change||-5.70%|
|3 Month Change||-14.15%|
|1 Year Change||-51.81%|
|3 Year Change||14.04%|
|5 Year Change||35.82%|
|Change since IPO||691.30%|
Recent News & Updates
|UK2||DE Medical Equipment||DE Market|
Return vs Industry: UK2 underperformed the German Medical Equipment industry which returned 0.3% over the past year.
Return vs Market: UK2 underperformed the German Market which returned -12.2% over the past year.
|UK2 Average Weekly Movement||9.1%|
|Medical Equipment Industry Average Movement||6.5%|
|Market Average Movement||6.4%|
|10% most volatile stocks in DE Market||10.7%|
|10% least volatile stocks in DE Market||3.5%|
Stable Share Price: UK2 is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: UK2's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment.
Shandong Weigao Group Medical Polymer Fundamentals Summary
|UK2 fundamental statistics|
Is UK2 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|UK2 income statement (TTM)|
|Cost of Revenue||CN¥5.90b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.49|
|Net Profit Margin||17.07%|
How did UK2 perform over the long term?See historical performance and comparison
2.1%Current Dividend Yield
Does UK2 pay a reliable dividends?See UK2 dividend history and benchmarks
|Shandong Weigao Group Medical Polymer dividend dates|
|Ex Dividend Date||Jun 09 2022|
|Dividend Pay Date||Jul 15 2022|
|Days until Ex dividend||24 days|
|Days until Dividend pay date||60 days|
Does UK2 pay a reliable dividends?See UK2 dividend history and benchmarks
Is Shandong Weigao Group Medical Polymer undervalued compared to its fair value and its price relative to the market?
Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: UK2 (€0.91) is trading below our estimate of fair value (€1.32)
Significantly Below Fair Value: UK2 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: UK2 is good value based on its PE Ratio (13.5x) compared to the German Medical Equipment industry average (30.3x).
PE vs Market: UK2 is good value based on its PE Ratio (13.5x) compared to the German market (17.7x).
Price to Earnings Growth Ratio
PEG Ratio: UK2 is good value based on its PEG Ratio (0.9x)
Price to Book Ratio
PB vs Industry: UK2 is good value based on its PB Ratio (1.6x) compared to the DE Medical Equipment industry average (2.9x).
How is Shandong Weigao Group Medical Polymer forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UK2's forecast earnings growth (14.9% per year) is above the savings rate (-0.05%).
Earnings vs Market: UK2's earnings (14.9% per year) are forecast to grow faster than the German market (8.1% per year).
High Growth Earnings: UK2's earnings are forecast to grow, but not significantly.
Revenue vs Market: UK2's revenue (13% per year) is forecast to grow faster than the German market (5% per year).
High Growth Revenue: UK2's revenue (13% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: UK2's Return on Equity is forecast to be low in 3 years time (11.7%).
How has Shandong Weigao Group Medical Polymer performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: UK2 has high quality earnings.
Growing Profit Margin: UK2's current net profit margins (17.1%) are lower than last year (18%).
Past Earnings Growth Analysis
Earnings Trend: UK2's earnings have grown by 15% per year over the past 5 years.
Accelerating Growth: UK2's earnings growth over the past year (7.6%) is below its 5-year average (15% per year).
Earnings vs Industry: UK2 earnings growth over the past year (7.6%) underperformed the Medical Equipment industry 41.4%.
Return on Equity
High ROE: UK2's Return on Equity (11.6%) is considered low.
How is Shandong Weigao Group Medical Polymer's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: UK2's short term assets (CN¥16.1B) exceed its short term liabilities (CN¥5.1B).
Long Term Liabilities: UK2's short term assets (CN¥16.1B) exceed its long term liabilities (CN¥4.3B).
Debt to Equity History and Analysis
Debt Level: UK2 has more cash than its total debt.
Reducing Debt: UK2's debt to equity ratio has increased from 9.8% to 19.4% over the past 5 years.
Debt Coverage: UK2's debt is well covered by operating cash flow (74.8%).
Interest Coverage: UK2 earns more interest than it pays, so coverage of interest payments is not a concern.
What is Shandong Weigao Group Medical Polymer current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Future Dividend Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: UK2's dividend (2.15%) is higher than the bottom 25% of dividend payers in the German market (1.37%).
High Dividend: UK2's dividend (2.15%) is low compared to the top 25% of dividend payers in the German market (4.29%).
Stability and Growth of Payments
Stable Dividend: UK2's dividend payments have been volatile in the past 10 years.
Growing Dividend: UK2's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (28.5%), UK2's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (33.8%), UK2's dividend payments are well covered by cash flows.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Rinan Cong (40 yo)
Mr. Rinan Cong serves as Chief Executive Officer at Shandong Weigao Group Medical Polymer Company Limited since March 30, 2021 and serves as Executive Director since May 24, 2021. He joined the Company in...
Experienced Management: UK2's management team is seasoned and experienced (5.8 years average tenure).
Experienced Board: UK2's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Shandong Weigao Group Medical Polymer Company Limited's employee growth, exchange listings and data sources
- Name: Shandong Weigao Group Medical Polymer Company Limited
- Ticker: UK2
- Exchange: DB
- Founded: 2000
- Industry: Health Care Supplies
- Sector: Healthcare
- Implied Market Cap: HK$34.965b
- Listing Market Cap: HK$4.279b
- Shares outstanding: 4.57b
- Website: https://www.weigaogroup.com
Number of Employees
- Shandong Weigao Group Medical Polymer Company Limited
- Torch Hi-Tech Science Park
- 18 Xingshan Road
- Shandong Province
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/14 00:00|
|End of Day Share Price||2022/05/13 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.